Trial Profile
An Observational Retrospective Study Comparing Ustekinumab Versus Secukinumab in Patients with Moderate to Severe Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- 09 May 2018 New trial record